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Strengths and limitations of this study
 ► This comprehensive scoping review will collate ex-
isting research findings around stress interventions 
in stroke survivors to inform future research and 
practice in this important area of stroke care.
 ► The iterative nature of scoping review data ex-
traction will ensure that all relevant evidence is 
collected.
 ► Consideration of the potential feasibility, acceptabili-
ty and cost- effectiveness of interventions will inform 
future research, which will assist in scaling up inter-
ventions to larger populations.
 ► The scoping review will include an assessment of 
study quality to rate existing evidence. This will help 
to identify potential gaps and areas to validate and 
address in future work.
 ► A limitation of this scoping review protocol is the ex-
clusion of grey literature and articles not published 
in English.
AbStrACt
Introduction Several studies have shown that stroke 
survivors report experiencing high and unremitting 
levels of stress, which can negatively affect brain repair 
processes and psychological outcomes and thereby 
compromise recovery. However, it is presently unclear 
which interventions have been trialled to manage stress 
in stroke survivors and whether they translate to clinically 
relevant outcomes. The aim of this scoping review will be 
to examine stress management interventions in stroke 
survivors in order to map the types of interventions trialled, 
commonly reported stress outcome measures and whether 
a reduction in stress contributes to reductions in relevant 
clinical outcomes.
Methods and analysis The methodological framework 
described in Arksey and O’Malley will be applied to 
this review. A draft search strategy was developed in 
collaboration with an experienced senior health research 
librarian. A systematic search of Medline, Embase, 
CINAHL, Cochrane library, PsycInfo and  Clinicaltrials. gov 
as well as hand searching of reference lists and reviews 
will identify relevant studies for inclusion. To be eligible 
for inclusion, studies must report on the outcomes of an 
intervention targeting stress management and resilience 
in stroke survivors. Study selection and critical appraisal of 
selected studies will be carried out independently by two 
authors, with discrepancies resolved by consensus. Data 
will be charted using a standard extraction form. Results 
will be tabulated and narratively summarised to highlight 
findings relevant to our research questions and to inform 
recommendations for future research.
Ethics and dissemination This study does not require 
ethics approval. This scoping review will provide a 
synthesis of evidence for stress management interventions 
in stroke survivors. It will identify and clarify the gaps in 
stress research specific to stroke pathologies and highlight 
promising interventions for future research. Findings will 
be relevant to researchers and healthcare workers and will 
be disseminated via publications in peer- reviewed journals 
and presented at conferences.
IntroduCtIon
Stroke affects around 17 million people world-
wide per year and is one of the leading causes 
of death and disability worldwide.1 2 The 
development of medical interventions that 
reduce the mortality rates of stroke means 
that a greater number of people survive 
stroke; however, approximately 25%–74% 
stroke survivors experience ongoing psycho-
logical comorbidities including cognitive 
impairment, anxiety and depression.3–6 Iden-
tifying risk factors that underlie the develop-
ment of these disorders is of vital importance 
to address and improve the recovery phase. 
Within the general population the develop-
ment of depression and anxiety is consis-
tently preceded by a stressful life event, which 
possesses a high level of psychological discom-
fort or unpleasantness.7 8 The potentially 
life- changing nature of stroke and the need 
for ongoing coordination of care services 
throughout recovery are likely to be signifi-
cant stressors that contribute to the aetiology 
of these outcomes for stroke survivors.
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Psychological stress appears to negatively impact the 
stroke recovery process, with a number of epidemio-
logical studies showing that greater levels of stress post-
stroke are associated with poorer long- term outcomes.9–13 
Ostwald et al,10 in a longitudinal study on the perceived 
stress of 159 stroke survivors, showed that higher func-
tional impairment in stroke survivors at discharge from 
inpatient rehabilitation was significantly associated with 
higher stress levels over a 1- year period. Dos Santos et al 
9 showed that perceived stress of stroke survivors after 
hospital discharge was positively correlated with depres-
sive symptoms, and negatively correlated with functional 
independence.9 Recently, in a cohort study of 182 stroke 
survivors, Tene et al12 showed that high salivary cortisol, 
a stress biomarker, was associated with worse cogni-
tive performance up to 2 years after stroke. In another 
study from the same cohort, Ben Assayag et al13 showed 
that higher levels of hair cortisol, thought to represent 
cumulative stress load over time, predicted worse cogni-
tive outcomes after stroke. Cognitive and psychological 
domains influenced by stress also contribute to poor 
motivation and well- being,14 which may further negatively 
impact participation in rehabilitation. Collectively, these 
studies highlight that stroke survivors with higher levels of 
stress post- stroke experience worse cognitive, functional 
and psychological outcomes.
Despite the mounting evidence that stroke survivors 
experience significant levels of stress connected to wors-
ened cognitive and psychological outcomes, stress is not 
routinely managed in clinical practice. Stress manage-
ment techniques have been trialled in the context of 
cardiovascular disease, however, with varying levels of 
success. The Enhanced Control of Hypertension and 
Thrombolysis Stroke Study trial assessed the impact of 
stress management within a comprehensive cardiac reha-
bilitation. The inclusion of stress management within a 
rehabilitation programme resulted in greater reduction 
in self- reported stress and reduced risk of adverse clinical 
events (clinical cardiovascular events including myocar-
dial infarction, coronary artery bypass grafts, death, 
stroke, severe angina and peripheral revascularisation) 
compared with cardiac rehabilitation alone.15 However, 
several other trials reported no benefit of stress manage-
ment training over the usual care. A large trial following 
2328 postmyocardial infarction patients receiving stress 
management or usual care showed no group differences 
in levels of anxiety or depression, or in the incidence of 
myocardial infarction, cerebrovascular accident, heart 
failure or revascularisation.16 Similarly, Frasure- Smith 
et al17 showed no differences in anxiety or depression 
between patients receiving monthly telephone moni-
toring of psychological distress and patients receiving 
usual care after myocardial infarction. Additionally, no 
difference in clinical cardiovascular outcomes was shown. 
A recent review of mind–body interventions for stress 
reduction in stroke survivors, including yoga, tai chi and 
mindfulness- based stress reduction, found that overall 
five quantitative trials had been published and none 
reported a significant difference in depression, anxiety or 
quality- of- life between intervention and control groups.18 
Overall, data from randomised trials in high- risk popula-
tions with cardiovascular disease, and stroke in particular, 
appears to be limited. The spread of findings suggest that 
deeper consideration needs to be given to the nature and 
timing of the interventions, as well as to their intended 
outcome and the way that the interventions are imple-
mented, resourced and measured. These characteristics 
will be considered in terms of the success and feasibility 
of the intervention to provide insight into important 
differences that may be associated with more beneficial 
approaches versus those that report no net impact.
Given the prevalence of stress during stroke recovery 
and its negative impact on the recovery process, the 
potential for a targeted stress intervention to optimise 
stroke outcomes is strong. However, due to the variety 
of interventions that have been trialled, differences 
in duration of delivery and follow- up, and potentially 
inconsistent ways of measuring stress (eg, psychometric 
vs biomarker approaches), at present, there is no clear 
intervention that can be considered to be more effective 
than others. Furthermore, it is uncertain whether changes 
in stress- related outcomes have been translated into clin-
ically relevant changes for stroke survivors. For instance, 
a corresponding decrease in anxiety and depression 
improved rehabilitation contacts and improvement in 
fatigue. Finally, the feasibility of any intervention must be 
considered; methods of stress intervention may be time 
consuming and difficult to scale up to larger populations, 
and acceptability of interventions is also important to 
improve adherence rates. In this scoping review, we there-
fore aim to synthesise existing results and approaches 
around stress interventions in stroke survivors to guide 
the development and implementation of stress manage-
ment in future studies and in practice.
 Aims and objectives
The broad aim of this scoping review is to map the avail-
able published evidence around stress interventions that 
have been trialled in stroke survivors. This will provide a 
comprehensive understanding of current evidence that 
will be used to clarify the gaps in knowledge and to guide 
the direction of future research. This protocol is designed 
to establish a methodology for conducting a scoping 
review, the aims of which comprise:
 ► To map the range of interventions trialled addressing 
stress management in stroke survivors and to iden-
tify which interventions show potential for further 
research.
 ► To identify potential findings which may help inform 
guidelines.
 ► To identify the average duration of follow- up of stress 
management studies.
 ► To map the range of outcome measures used for 
stress.
 ► To identify whether early intervention for stress trans-
lates into a reduction in stress- associated disorders, 
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including depression, anxiety and post- traumatic 
stress disorder.
 ► To identify barriers and limitations to implementing 
stress interventions.
 ► To identify which interventions are feasible and 
acceptable for stroke survivors.
 ► To consider the potential cost- effectiveness of stress 
interventions.
The protocol will be reported using the Preferred 
Reporting Items for Systematic Review and Meta- Analysis 
Protocols checklist,19 adapted for a scoping review using 
the Preferred Reporting Items for Systematic Reviews and 
Meta- Analyses (PRISMA) Extension for Scoping Reviews20 
(online supplementary appendix 1).
MEthodS And AnAlySIS
We are applying a scoping review methodology as it offers 
an opportunity to broadly map and summarise existing 
research findings and identify gaps in existing evidence. 
We expect this to be an area where the implementation of 
interventions and measurement of outcomes is likely to 
be heterogeneous; therefore, a systematic review, which 
aims to provide a synthesised result for a more specific 
research question, would not be appropriate. The frame-
work to be used in the scoping review was first outlined 
by Arksey and O’Malley21 and involves identifying the 
research question; identifying relevant studies; study 
selection; charting of the data; and collating, summarising 
and reporting the results. Methodological approaches 
by Peters et al,22 Levac et al 23 and in the Joanna Briggs 
Institute Reviewers’ Manual24 will also be considered. 
Reporting will be conducted according to the PRISMA 
Extension for Scoping Reviews.20 This scoping review was 
initiated on the 1 March 2019 and is to be completed by 
January 2020.
 Stage 1: identifying the research questions
A scoping review comprises an iterative process for devel-
oping one or more guiding research questions, where 
each revision is driven by increasing familiarity with 
the literature. Initially, broad research questions were 
conceived to ensure that the review would capture the 
diversity and scope of the literature available. It is our 
intention to comprehensively examine the literature 
describing stress interventions that have been trialled in 
stroke survivors, and as we do so the research questions 
may be reformulated, and new questions may appear over 
time. The research questions are outlined in the aims and 
objectives section of the introduction to this protocol.
 Stage 2: identifying relevant studies
The aim of the scoping review is to comprehensively 
address broad research questions and will be informed by 
a systematic search strategy. The initial search strategy was 
developed in consultation with a senior health research 
librarian. The strategy drew on the work of the Cochrane 
Stroke Group to operationalise terms for stroke survivor, 
stress and intervention study. Publication titles from a 
preliminary search were reviewed to inform refinement 
in consultation with the research team. This included 
the addition of ‘resilience’ and ‘optimism’. The search 
strategy was developed in Medline and expanded to 
Embase, PsycInfo, CINAHL and the Cochrane library. 
Database searches were restricted to human subjects and 
English language citations only. No date or publication 
type limits were applied.
We will manually search the reference lists of all 
included studies as well as relevant systematic reviews. Full 
details of the initial draft search strategy are included in 
the supplementary appendix to this manuscript (online 
supplementary appendix 2). The initial search, which was 
conducted on 11 March 2019, identified 3820 references, 
which were imported into Endnote and duplicates elim-
inated. After deduplication, 2653 references were avail-
able for screening.
 Stage 3: study selection
Studies identified in the search will be collated in 
EndNote X8.2 and exported to Covidence for screening 
of titles and abstracts, and full- text reviews. All titles and 
abstracts will be independently reviewed by two authors 
according to the proposed eligibility criteria (see table 1), 
and conflicts will be resolved in consultation with a third 
author. When consensus is not reached, that article will 
be included in the next stage of the review. Following 
title and abstract screening, full texts of potentially rele-
vant studies will be assessed for eligibility by two authors 
independently, with any conflicts resolved by consensus 
among authors. Review authors will communicate regu-
larly during the screening process to discuss study selec-
tion, with any alterations recorded. The selection process 
will be reported using a PRISMA flow diagram.25
The proposed inclusion and exclusion criteria are 
summarised in table 1.
While scoping review methodology does not specify 
a process for evaluating study quality, we will critically 
appraise all included papers. This is primarily because 
the search is limited to intervention studies, and we want 
to enable both an assessment of the quality of existing 
evidence and facilitate identification of evidence gaps, 
including where the quality of existing research does 
not enable a specific recommendation to be made. We 
will use The Cochrane Collaboration’s tool for assessing 
risk of bias26 to assess the quality of quantitative studies 
and the Consolidated Criteria for Reporting Qualitative 
Research checklist27 to assess the quality of any qualitative 
studies that are identified. Study appraisal will be carried 
out by two independent authors, with any discrepancies 
found in assessments resolved by consensus among all 
authors if necessary.
 Stage 4: charting the data
Data charting is the method used for extracting data in 
scoping reviews.21–24 Data charting is a comprehensive 
assembly of study results and characteristics, which allows 
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Table 1 Study selection criteria
Inclusion Exclusion
Population Survivors of stroke or transient ischemic attack. Non- human subjects (eg, preclinical 
studies)
Any age group.
Intervention Any Nil exclusion criteria
Comparator Any Nil exclusion criteria
Outcome Stress resilience Nil exclusion criteria
Publication Published intervention studies of any design (quantitative or 
qualitative), including randomised controlled trials, quasi- 
experimental designs, and pre- test and post- test designs
Reviews
Commentaries/opinion papers
Letters
Meta- analyses
Not published in English
Unpublished studies (eg, protocols)
researchers to capture the span of information within the 
incorporated studies including context. We will develop 
a standardised electronic form in Excel to chart the data. 
For each source, data will be charted by one author and 
checked by a second author. Any discrepancies will be 
resolved by consensus among authors. Data extraction 
will be an iterative process, incorporating an initial trial 
of data charting and team consultation throughout the 
process to ensure consistency with review questions and 
purpose and include new questions that arise during the 
process. Regular communication between authors will 
facilitate this process and ensure the reliability of data 
charting. All significant alterations to the data chart will 
be recorded.
Preliminary study details and outcomes chosen for 
charting were guided by The Cochrane Collabora-
tion’s Checklist of items to consider in data collection 
extraction26 and the recommendations published in Arksey 
and O’Malley21 and Peters et al.22 24 Based on preliminary 
discussions, we developed a number of categories that 
will guide the extraction and charting of the data from 
the full- text publications. This is based on providing the 
data necessary for addressing the main objective of this 
review, that is, to map the breadth of interventions trialled 
for stress in stroke populations to date. Presently, these 
categories include (but are not limited to): bibliographic 
information; study aims/purpose; research design; 
number of participants; participant characteristics such as 
stroke type and sociodemographic; duration of interven-
tion and follow- up; setting; date; country; comorbidities; 
and all reported outcome measures. Data to be charted 
on the stress intervention will include frequency, intensity, 
time and description of intervention and any control or 
comparison groups; the number of intervention groups; 
adherence; and satisfaction. Details of outcomes that 
inform secondary research questions including economic 
viability, intervention feasibility and acceptability, and 
intervention safety will be included. If additional data 
extraction categories emerge during the process, these 
may be added in consultation with the research team and 
will be reported along with the findings.
 Stage 5: collating, summarising and reporting results
The purpose of a scoping review is to map research 
findings and present an overview, rather than system-
atic synthesis of evidence, which provides results on a 
narrowly defined question. Therefore, this review is still 
an iterative work in progress. Using this methodology, we 
will be able to identify gaps in the research and action 
areas, which will inform where more in- depth analysis 
and additional research is required. The results will be 
summarised and reported to prioritise the findings rele-
vant to the specific research questions. Quantitative data 
and the results of individual studies’ critical appraisal will 
be tabulated by type of intervention. Any qualitative data 
will be analysed thematically and reported either narra-
tively or tabulated. Additionally, further narrative descrip-
tion of all results will be provided to aid interpretation 
of the findings as they relate to the research questions 
(both those originally defined, as well as new questions 
that emerge throughout the review process). A narrative 
approach will also be used to highlight gaps in existing 
research evidence. The overall results will be used to 
make recommendations for future research priorities 
and practice relating to stress management and resilience 
building techniques for stroke survivors.
The review will be interpreted within the constraints 
of its limitations. As we are not including grey literature, 
potentially relevant publications may be missed. Our deci-
sion to include only scientific publications was to ensure 
research quality can be assessed to aid identification of 
gaps in knowledge and research priorities in future. Any 
additional limitations identified throughout the scoping 
review will be acknowledged in the publication of the 
review.
 Statement of patient and public involvement
There will be no patient or public involvement in this 
review.
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 Ethics and dissemination
The completed review will be published in a peer- 
reviewed journal, and findings will be further dissem-
inated through presentation at appropriate forums 
or conferences. Results will also be used to inform the 
development of future research assessing scalable inter-
ventions for stress management in stroke survivors. Only 
secondary data from published sources will be included 
in the scoping review; therefore, ethics approval is not 
required.
dISCuSSIon
Stress is emerging as a significant risk factor for poor stroke 
recovery outcomes, and the best approach to managing 
stress within this population must be identified. To the 
best of our knowledge, this is the first review to map the 
effectiveness of stress interventions among stroke survi-
vors. This scoping review protocol provides the chosen 
approach to synthesising a variety of research evidence 
in a field that is largely disparate. One of the strengths 
of the proposed review is to identify stress management 
interventions that could potentially improve the recovery 
trajectory of stroke survivors. We also anticipate that the 
findings of this scoping review will identify priorities 
for future intervention studies and will identify gaps in 
current stress intervention research, considering the 
breadth of existing research in the field in relation to 
efficacy, safety, economics, acceptability and feasibility of 
interventions for stress and resilience. This review may 
also have implications beyond stroke care, to consider 
stress management in other areas of rehabilitation and 
recovery where stress is likely to play a similarly signifi-
cant role. The outcomes of this review will be relevant to 
researchers, clinicians and policymakers both national 
and internationally.
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